OpenAI acquires Orchestra Bio
Summary
OpenAI's acquisition of Orchestra Bio brings AI-driven operations into life sciences R&D, helping biopharma teams speed up drug development and push new therapies forward.
Why this matters
Official source · Relevant to this topic
Source: OpenAI News · openai.com